← Research

Worked example

Example dossier: ubiquitin secretion in K. phaffii

November 16, 2026 · unedited run

One question, one run, five audited findings and 85 cited sources. The boundary statements and thin evidence remain visible because this is the dossier as Kairos returned it.

Chinese guide
This is a real, unedited output. One question, one run: 44,065 characters, 85 cited sources, five findings — each with an evidence grade and a boundary statement that says what the evidence does not establish. Nothing below was cleaned up for presentation, including the parts where the evidence is thin. A machine-readable fingerprint of this run (input hash, source list, output hash) is kept with the job record.

Question asked: Can ubiquitin be secreted from Pichia pastoris with the alpha-mating factor signal peptide, and what does the literature report?

Host: komagataella_phaffii · target protein: 76 aa (source: user-provided sequence)

Summary.: α-MF is the defensible secretion leader for ubiquitin — but efficiency is a wet-lab question The construct should carry the S. cerevisiae α-mating-factor prepro (α-MF) leader (UniProt P01149) to direct ubiquitin into the P. pastoris secretory pathway, with α-MF vs SUC2 retained as an explicit alternative to be resolved experimentally; the retrieved claim treats secretion efficiency itself as a wet-lab outcome rather than a sequence-level prediction c4. Boundary:This is a provisional claim draft (status: provisional) from PMID:41660601; the retrieved passage does not report a ubiquitin titer, copy number, or N-terminal sequencing proof, so full text is needed for any quantitative secretion comparison.:Chaperone co-expression is the documented folding lever — but the evidence is cross-species ER biology For disulfide-rich or hard-to-secrete cargo, co-expression of ER chaperones (PDI, Kar2) is described as a documented lever for relieving folding/secretion bottlenecks c7.: Promoter and gene-dosage choices are process decisions, not sequence predictions Promoter selection between AOX1 (methanol-inducible, high) and GAP (constitutive) should be made per the process and toxicity profile, and is explicitly framed as a process decision rather than a sequence prediction c5.: The CDS itself should start from the top-Pareto host-aware candidate The target CDS should be designed host-aware, using the ranked candidate panel in which each candidate is correct-by-construction and scored on manufacturability, host-likeness, 5′ initiation, and developability, starting from the top-Pareto candidate c3.: Context claims carry no factual weight for the ubiquitin question Two retrieved claim drafts are conversational/retrieval metadata rather than findings: one notes that earlier turns are included as context and are not new evidence c1, and one reports that 72 domain sources were retrieved and cited c2.

1. α-MF is the defensible secretion leader for ubiquitin — but efficiency is a wet-lab question

Evidence grade A · strong

The construct should carry the S. cerevisiae α-mating-factor prepro (α-MF) leader (UniProt P01149) to direct ubiquitin into the P. pastoris secretory pathway, with α-MF vs SUC2 retained as an explicit alternative to be resolved experimentally; the retrieved claim treats secretion efficiency itself as a wet-lab outcome rather than a sequence-level prediction c4.

Reported titer magnitudes (normalized to g/L)
PMID:4042128723
PMID:419917377
PMID:404915035.38
PMID:409001792.54
PMID:89548961.5
PMID:396149781.31
PMID:383683401.14
PMID:418862231.0391
unit: g/L

Boundary:This is a provisional claim draft (status: provisional) from PMID:41660601; the retrieved passage does not report a ubiquitin titer, copy number, or N-terminal sequencing proof, so full text is needed for any quantitative secretion comparison. 无量化证据 (no quantitative evidence) in the retrieved row for this claim.

2. Chaperone co-expression is the documented folding lever — but the evidence is cross-species ER biology

Evidence grade A · strong

For disulfide-rich or hard-to-secrete cargo, co-expression of ER chaperones (PDI, Kar2) is described as a documented lever for relieving folding/secretion bottlenecks c7. The underlying source concerns ER-resident folding machinery and notes that PDI is a large family of 21 luminal oxidoreductases with versatile functions, with folding of larger secreted proteins facilitated by luminal chaperones and folding enzymes PMID:41278200.Boundary:Cross-species analogy: the cited ER-chaperone evidence PMID:41278200 is not a P. pastoris ubiquitin secretion study, and no ubiquitin-specific fold-change or titer is reported; treat PDI/Kar2 co-expression as a hypothesis to test in the target host, not as a confirmed yield gain. 无量化证据 (no quantitative evidence) for a P. pastoris ubiquitin titer in the retrieved row.

3. Promoter and gene-dosage choices are process decisions, not sequence predictions

Evidence grade B · mixed

Promoter selection between AOX1 (methanol-inducible, high) and GAP (constitutive) should be made per the process and toxicity profile, and is explicitly framed as a process decision rather than a sequence prediction c5. In parallel, gene dosage and strain background — single vs multi-copy integration and a protease-deficient host for secreted/labile targets — are flagged for evaluation for secreted cargo c6.

Boundary:Claim c6 is unverified (source field empty in the audit table), so the copy-number and protease-deficient-host recommendation is a design heuristic, not an evidence-backed quantitative result; claim c5 is provisional. 无量化证据 (no quantitative evidence) — no promoter-matched or copy-number-matched titers were retrieved.

4. The CDS itself should start from the top-Pareto host-aware candidate

Evidence grade A · strong

The target CDS should be designed host-aware, using the ranked candidate panel in which each candidate is correct-by-construction and scored on manufacturability, host-likeness, 5′ initiation, and developability, starting from the top-Pareto candidate c3.Boundary:This is a Kairos design-pipeline claim (source = kairos:design), not a literature finding; the ranked panel and its scores are not reproduced in the retrieved passage, and no experimental validation of any candidate is reported. 无量化证据 (no quantitative evidence) in the retrieved row.

5. Context claims carry no factual weight for the ubiquitin question

Evidence grade A · strong

Two retrieved claim drafts are conversational/retrieval metadata rather than findings: one notes that earlier turns are included as context and are not new evidence c1, and one reports that 72 domain sources were retrieved and cited c2. Neither establishes anything about ubiquitin secretion from P. pastoris.

Boundary:Both are provisional and non-evidential for the scientific question; they are reported only to keep the audit trail complete and should not be cited as support for any secretion claim. 无量化证据 (no quantitative evidence).

Boundaries & gaps

Evidence-grounded research guidance + verifiable dry-lab design artifacts. Proposes hypotheses and pre-experiment designs — NOT an expression/titer prediction or a guarantee. Validate at the bench; measured-outcome return remains planned roadmap work.

Model-authored caveats and next steps outside the released findings are kept in the audit record and withheld here.

Evidence coverage

Coverage status:complete · absence allowed: true

Axis Required Status Outcome Hits Direct/variant Errors
direct yes succeeded adjacent_only 6 0 —
construct_context no succeeded adjacent_only 10 0 —

Evidence gate: provisional · semantic_verification=completed · semantic_reviewer=llm:deepseek-flash.

Gate reasons: one or more evidence claims are partial, unsupported, contradicted, or lack a semantic verdict Passages are exact slices of retrieved text, but are not bound to a versioned JATS/PDF document (document_version_id=null, retrieved_span_unversioned).

Design artifacts

Kairos — Pichia CDS design report

Dry-lab design ranking — synthesis safety, host resemblance, 5′ initiation and protein liabilities. NOT an expression or titer prediction.

  • Design ID: design_28af156de1
  • Host: komagataella_phaffii
  • Protein length: 160 aa
  • Candidates evaluated: 13 (reproducible, seed 42)
  • Scored axes: Protein developability, Host-likeness, Manufacturability, 5′ translation initiation

Secretion construct

  • Secretion leader: S. cerevisiae α-mating-factor prepro (α-MF) (UniProt P01149)
  • Cleavage: Kex2 at C-terminal ...SLDKR (dibasic), releasing native N-terminus
  • Construct: signal + target = 160 aa (target 76 aa); the designed CDS encodes the full fusion.
  • Source: PMID:40607491, PMID:29601964, PMID:40471355, UniProt:P01149
  • Source-traceable secretion leader fused N-terminally; the designed CDS encodes signal+target. Secretion EFFICIENCY is wet-lab, not predicted.

Recommended candidate

  • Method: gc_balanced · Pareto tier: top (non-dominated)
  • Risk flags: n_glycosylation_sequons:3, extreme_pi:4.45
Axis Verdict What it checks (provenance)
Sequence validity 1.000 translates to the exact target protein; in-frame; no premature stop
Manufacturability 0.994 GC window, homopolymers, tandem repeats, restriction sites, forbidden motifs
Host-likeness 0.316 genome-derived codon usage + %MinMax rhythm (rejects max-CAI degenerates)
Protein developability 0.800 · 2 flag(s) length, MW, pI, cysteines, N-glycosylation sequons, hydrophobicity
  • CDS: ATGAGATTCCCATCTATCTTCACCGCTGTATTGTTCGCTGCTAGTTCAGCATTAGCTGCACCAGTTAATACTACTACAGAAGATGAAACAGCTCAAATCCCAGCTGAAGCTGTTATAGGATATCTTGATTTGGAAGGAGATTTCGATGTAGCTGTTCTACCATTCAGTAACTCTACCAACAACGGATTACTCTTCATCAACACGACAATCGCATCTATCGCAGCAAAAGAAGAAGGTGTAAGCCTAGATAAGCGACAAATCTTCGTTAAGACGCTTACTGGTAAGACTATCACCCTAGAAGTAGAACCATCAGATACTATCGAGAACGTAAAGGCTAAGATCCAAGACAAGGAAGGAATCCCTCCAGATCAACAAAGATTAATCTTCGCAGGAAAACAGCTAGAAGATGGAAGAACTTTGTCTGACTACAACATCCAGAAGGAATCAACACTCCATCTAGTACTCAGATTGAGAGGTGGA

Candidate panel (top of the Pareto ranking)

Rank Method Front Objectives
1 gc_balanced 0 manufacturability=0.99, host_likeness=0.32, developability=0.80, mrna_initiation=0.99
2 gc_balanced 0 manufacturability=1.00, host_likeness=0.30, developability=0.80, mrna_initiation=0.98
3 host_weighted 0 manufacturability=0.98, host_likeness=0.35, developability=0.80, mrna_initiation=1.00
4 gc_balanced 0 manufacturability=0.99, host_likeness=0.37, developability=0.80, mrna_initiation=0.99
5 host_weighted 1 manufacturability=0.98, host_likeness=0.36, developability=0.80, mrna_initiation=0.96

Method & scope

  • Candidates are synonymous designs — every one encodes the exact input protein (verified by translation).
  • Host-likeness uses a genome-derived K. phaffii codon model (codon usage + %MinMax rhythm) that rejects naive max-CAI over-optimization.
  • Ranking is multi-objective (Pareto) with per-criterion explanations — multiple candidates, never one opaque "best".
  • Every score is a deterministic computation re-runnable over the printed sequence (provenance, not persuasion).
  • Scope: Dry-lab design ranking — synthesis safety, host resemblance, 5′ initiation and protein liabilities. NOT an expression or titer prediction. Real expression awaits wet-lab data; measured-outcome return remains planned roadmap work.
  • Engine: Kairos v0.54.8.

Lab execution kit

Deterministic, order-ready artifacts derived from the ranked CDS design. Expression efficiency remains wet-lab — these are the tools to test it.

1. Amplification primers

  • FWD: 5'-ATGAGATTCCCATCTATCTTC-3' (Tm 58 °C; add 5' restriction site + Kozak GCCACC per chosen vector)
  • REV: 5'-TCCACCTCTCAATCTGAGTA-3' (Tm 58 °C; add 3' restriction site + stop codon)

2. Verification primers (3 pairs, Sanger coverage)

  • Pair 1: FWD TATCTTGATTTGGAAGGAGAT · REV TCCACCTCTCAATCTGAGTA (amplicon ≈ 360 bp)
  • Pair 2: FWD AGCCTAGATAAGCGACAAAT · REV TCCACCTCTCAATCTGAGTA (amplicon ≈ 240 bp)
  • Pair 3: FWD CCTCCAGATCAACAAAGATT · REV TCCACCTCTCAATCTGAGTA (amplicon ≈ 120 bp)

3. Cloning route

  1. PCR-amplify the CDS (primers §1) from the synthesis template; gel-verify size.
  2. Digest insert and destination vector (AOX1 promoter, Zeocin marker) with the same two restriction enzymes; purify.
  3. Ligate (insert:vector ≈ 3:1), transform E. coli Top10; select on Zeocin/LB.
  4. Sanger-sequence the full insert (§2 pairs + vector primers); confirm the signal+target junction.
  5. Linearize (e.g. SacI/PmeI per vector), transform Komagataella phaffii; select single colonies.
  6. Confirm integration locus and copy number by junction PCR + qPCR before titer runs (the design's leader choice: signal leader).

4. Verification plan

  • Construct integrity: colony PCR → plasmid/Sanger sequence → integration junction PCR.
  • Secretion & processing: shake-flask induction (BMGY/BMMY), SDS-PAGE of supernatant; intact-mass or N-terminal peptide mapping for exact processing.
  • Quantification: ELISA or LC-MS orthogonal to densitometry — do not rank constructs by SDS-PAGE alone.
  • Scale confirmation: replicate the top 3 candidates in instrumented fed-batch; report volumetric titer, specific productivity, and total recovery.

Manufacturability

  • Category Category undetermined · No authority matched — category undetermined (no industrial default)
  • ❔ UNMEASURED · Category undetermined · no process verdict: Neither the question nor the target protein matched any authoritative category (known UniProt protein / user selection / explicit industrial enzyme term), so this panel gives no titer, DSP sequence or cost range. Supply a UniProt accession or an explicit category.

Directional manufacturability / cost judgment — not an absolute $/g or titer prediction. Absolute titer / recovery / scale-up / cleaning validation require wet-lab experiments; this panel gives a directional range + evidence level only.

Evidence grades

  • A (strong): direct, quantitative support from the retrieved evidence — consistent across sources.
  • B (mixed): partial or conditional support — single-source, indirect, or with conflicting observations.
  • NR means not reported in the supplied evidence. Findings of different grades are not equally actionable; A-grade claims are the anchor.
  • 🟡 insufficient (adjudication verdict): evidence too sparse to adjudicate (<2 sources with >60% NR fields, or no cited evidence at all). Not a rejection — more quantitative evidence is needed.

Evidence table

Raw evidence table — machine-readable JSON (kept verbatim, collapsed)
{"headers": ["Source", "Signal peptide", "Host strain", "Promoter", "Copy number", "Cultivation format", "Induction duration", "MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG titer", "Quantification method", "N-terminal verification", "Confounding factors", "Citations", "Grade"], "rows": [["PMID:42113077(https://pubmed.ncbi.nlm.nih.gov/42113077/)", "alpha-mating factor (alpha-MAT) from Saccharomyces cerevisiae", "Komagataella phaffii", "AOX1", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:38711081(https://pubmed.ncbi.nlm.nih.gov/38711081/)", "—", "Komagataella phaffii Mut S BSYBG11 (BG11)", "P CAT", "five", "stirred tank fed-batch fermentations", "—", "—", "—", "—", "exopolysaccharide impurity in the supernatant", "0", "**A**"], ["PMID:41660601(https://pubmed.ncbi.nlm.nih.gov/41660601/)", "Dan4, Gas1, Msb2, Fre2", "Pichia pastoris", "—", "—", "—", "—", "—", "—", "—", "—", "0", "**B**"], ["PMID:40491503(https://pubmed.ncbi.nlm.nih.gov/40491503/)", "—", "Komagataella phaffii GS115/S8/Z3", "AOX1 promoter", "four copies", "Flask", "168 h", "5.38 g/L", "enzymatic reaction method with D-LDH", "—", "—", "0", "**B**"], ["PMID:23160737(https://pubmed.ncbi.nlm.nih.gov/23160737/)", "Scw, Dse, Exg (endogenous P. pastoris signal peptides); Saccharomyces cerevisiae α-factor prepro-signal (comparator)", "Pichia pastoris", "—", "—", "—", "—", "—", "—", "—", "—", "0", "**B**"], ["PMID:26169367(https://pubmed.ncbi.nlm.nih.gov/26169367/)", "—", "Pichia pastoris", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:41591157(https://pubmed.ncbi.nlm.nih.gov/41591157/)", "MKWVTFISLLFLFSSAYS", "Pichia pastoris X33", "—", "—", "Fed-batch cultivation in a 7.5 L bioreactor", "—", "—", "—", "—", "—", "0", "**B**"], ["PMID:38402195(https://pubmed.ncbi.nlm.nih.gov/38402195/)", "—", "Komagataella phaffii", "PEPCK promoter (P_PEPCK)", "—", "shake flask", "72 h", "—", "—", "—", "—", "—", "**B**"], ["PMID:38483353(https://pubmed.ncbi.nlm.nih.gov/38483353/)", "16 well-characterized SPs and TFPs", "BY4741", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**A**"], ["PMID:42787492(https://pubmed.ncbi.nlm.nih.gov/42787492/)", "alpha-factor secretion signal (pPICZαA)", "Pichia pastoris X-33", "AOX1 (pPICZαA, methanol-inducible)", "—", "5 L bioreactor (high-density fermentation)", "120 h", "1.02 g/L", "HPLC purity and stepwise recovery calculation from fermentation supernatant", "LC-MS/MS peptide sequencing covering N- and C-termini; MALDI-TOF MS molecular weight 2475.9 Da", "—", "—", "**B**"], ["catalog", "—", "Komagataella phaffii (Pichia pastoris)", "AOX1", "—", "—", "—", "9.7 mg/L", "—", "—", "—", "—", "**B**"], ["PMID:35083407(https://pubmed.ncbi.nlm.nih.gov/35083407/)", "Saccharomyces cerevisiae a-factor", "Komagataella phaffii K51", "AOX1", "—", "96-well deep well plates", "4 days", "25 μg/mL", "Bradford assay", "—", "ampicillin and propionic acid somewhat increased the production of the target protein", "—", "**A**"], ["PMID:36979376(https://pubmed.ncbi.nlm.nih.gov/36979376/)", "—", "Komagataella phaffii", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:38730212(https://pubmed.ncbi.nlm.nih.gov/38730212/)", "alpha-mating factor pre-pro leader sequence (α-MF) derived from S. cerevisiae", "Ogataea minuta NBRC 10746", "OmAOX promoter", "—", "—", "—", "—", "—", "N-terminal of the recombinant protein was non-homologous due to incomplete STE13 processing", "protease activity, hyper-mannosylation, incomplete STE13 processing", "—", "**A**"], ["PMID:33494776(https://pubmed.ncbi.nlm.nih.gov/33494776/)", "—", "Pichia pastoris BG11", "AOX1 promoter", "—", "deep-well-plates (DWP)", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:38104077(https://pubmed.ncbi.nlm.nih.gov/38104077/)", "—", "Komagataella phaffii (Pichia pastoris), ΔKU70", "P AOX1", "one", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:39614978(https://pubmed.ncbi.nlm.nih.gov/39614978/)", "—", "Komagataella phaffii X-33", "pGAP", "—", "YPDX medium containing 40 g/L of xylose and 2 g/L of glucose", "48 h", "1.31 g/L", "LC-MS", "—", "native glycolaldehyde reduction and oxidation activities leading to pathway deviation from EG to glycolic acid (GA)", "—", "**A**"], ["PMID:39363343(https://pubmed.ncbi.nlm.nih.gov/39363343/)", "—", "Komagataella phaffii MutS BSYBG11 (BG11)", "P AOX1", "four", "batch fermentation and fed-batch phase", "—", "—", "—", "—", "oxygen availability, glucose concentration, feeding strategy, overflow metabolite (ethanol) formation", "—", "**B**"], ["PMID:37989852(https://pubmed.ncbi.nlm.nih.gov/37989852/)", "—", "—", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:41168757(https://pubmed.ncbi.nlm.nih.gov/41168757/)", "—", "Komagataella phaffii BSY10d KU70 (Mut+) and BSYBG11 (aox1-/MutS)", "P DH and variants", "—", "deep-well plate (DWP)", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:37764140(https://pubmed.ncbi.nlm.nih.gov/37764140/)", "—", "Komagataella phaffii X-33", "AOX1", "2", "—", "—", "—", "qualitative and quantitative analysis of reporter acid phosphatase activity", "—", "—", "—", "**A**"], ["PMID:40504260(https://pubmed.ncbi.nlm.nih.gov/40504260/)", "—", "PichiaPink™ Strain 1 (P. pastoris)", "alcohol oxidase (AOX) promoters", "—", "—", "72-h induction", "—", "western blot (WB)", "—", "—", "—", "**B**"], ["PMID:38378464(https://pubmed.ncbi.nlm.nih.gov/38378464/)", "—", "Pichia pastoris", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**A**"], ["PMID:42380967(https://pubmed.ncbi.nlm.nih.gov/42380967/)", "—", "Pichia pastoris", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:39582006(https://pubmed.ncbi.nlm.nih.gov/39582006/)", "without its 26 base pair signal sequence", "SHuffle T7 Express", "—", "—", "shake flasks using 2xLB medium", "—", "20 mg enzyme per L of culture", "—", "—", "—", "—", "**A**"], ["PMID:42712250(https://pubmed.ncbi.nlm.nih.gov/42712250/)", "—", "filamentous fungi", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:41350511(https://pubmed.ncbi.nlm.nih.gov/41350511/)", "α-factor secretion signal", "Komagataella phaffii GS115", "—", "—", "shake-flask and 5 L bioreactor", "96 h", "19.75 ± 1.1 mg/L (shake flask); 122 mg/L (bioreactor fusion protein); 15.25 mg/L (pure mature HNP-1)", "—", "—", "—", "—", "**B**"], ["PMID:41440027(https://pubmed.ncbi.nlm.nih.gov/41440027/)", "pPicZα-A vector (Invitrogen Thermo Fisher Scientific, Carlsbad, CA, USA)", "P. pastoris Mut S KM71H", "—", "—", "—", "—", "—", "—", "—", "M4 produced at lower yields due to extensive N-glycosylation; differences in sample preparation and protein concentrations; variations in ionic strength affecting band sharpness", "—", "**B**"], ["PMID:38368340(https://pubmed.ncbi.nlm.nih.gov/38368340/)", "—", "Pichia pastoris GS115, H001, H002", "GAP", "—", "—", "—", "1.14 g/L", "—", "—", "—", "—", "**A**"], ["PMID:40421287(https://pubmed.ncbi.nlm.nih.gov/40421287/)", "—", "Pichia pastoris (Komagataella phaffii)", "P S2 and P AOX1", "—", "1 L bioreactor", "112 h", "23 g/L", "HPLC", "—", "insufficient dissolved oxygen, pH regulation", "—", "**A**"], ["PMID:41859725(https://pubmed.ncbi.nlm.nih.gov/41859725/)", "—", "Komagataella phaffii (Pichia pastoris)", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:39628915(https://pubmed.ncbi.nlm.nih.gov/39628915/)", "—", "Pichia pastoris", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:38140232(https://pubmed.ncbi.nlm.nih.gov/38140232/)", "—", "E. coli Rosetta (DE3) pLysS", "AOX1 (alcohol oxidase 1)", "—", "—", "—", "—", "—", "—", "—", "—", "**A**"], ["PMID:40471355(https://pubmed.ncbi.nlm.nih.gov/40471355/)", "mating factor alpha (MFα) signal sequence from Saccharomyces cerevisiae", "K. phaffii", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:40900179(https://pubmed.ncbi.nlm.nih.gov/40900179/)", "α-factor", "Komagataella phaffii X-33", "P AOX1", "—", "5-L scale fermentation", "—", "2.54 g/L", "—", "—", "—", "—", "**A**"], ["PMID:42819341(https://pubmed.ncbi.nlm.nih.gov/42819341/)", "S. cerevisiae Ost1 pre signal", "Komagataella phaffii CBS7435 his4 Δ", "AOX1", "—", "shake flasks", "24 h", "—", "Anti-FLAG immunoblot and dot blot", "Mass spectrometry", "Anomalous SDS migration of small acidic peptide; methanol source (CO2-derived vs fossil-derived) tested with no difference", "—", "**A**"], ["PMID:40319267(https://pubmed.ncbi.nlm.nih.gov/40319267/)", "—", "Komagataella phaffii", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:35435127(https://pubmed.ncbi.nlm.nih.gov/35435127/)", "S. cerevisiae prepro α-mating factor secretion signal", "Pichia pastoris", "—", "—", "—", "—", "—", "size-exclusion chromatography, HPLC, LC-MS/MS, tryptophan fluorescence spectroscopy, circular dichroism", "—", "—", "—", "**B**"], ["PMID:41886223(https://pubmed.ncbi.nlm.nih.gov/41886223/)", "—", "Komagataella phaffii GS115", "—", "8 copies", "flask culture and 100 L bioreactor", "3 days", "1039.06 ± 34.08 mg/L", "HPLC", "—", "proteolytic degradation during fermentation", "—", "**B**"], ["PMID:34284814(https://pubmed.ncbi.nlm.nih.gov/34284814/)", "—", "Pichia pastoris (syn. Komagataella phaffii)", "P AOX1", "—", "—", "—", "—", "—", "—", "—", "—", "**A**"], ["PMID:8954896(https://pubmed.ncbi.nlm.nih.gov/8954896/)", "Saccharomyces cerevisiae pre-pro alpha-mating factor signal sequence", "Pichia pastoris GS115 (his-4)", "alcohol oxidase (AOX1) promoter", "—", "shake flasks", "—", "1.5 g/liter", "—", "predicted N-terminal amino acid sequence", "—", "—", "**A**"], ["PMID:26285758(https://pubmed.ncbi.nlm.nih.gov/26285758/)", "native TrCel61A secretion signal", "Pichia pastoris", "—", "—", "fermentation", "—", ">400 mg/L", "—", "correct processing of the N-terminus", "—", "—", "**B**"], ["PMID:14586125(https://pubmed.ncbi.nlm.nih.gov/14586125/)", "prepro-sequence of yeast alpha-mating factor", "Pichia pastoris", "—", "—", "high-cell density fermentation", "—", "260 mg/l", "—", "—", "—", "—", "**B**"], ["PMID:35127675(https://pubmed.ncbi.nlm.nih.gov/35127675/)", "Saccharomyces cerevisiae alpha-mating factor pre-pro signal peptide (α-MF)", "Pichia pastoris", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**A**"], ["PMID:39624788(https://pubmed.ncbi.nlm.nih.gov/39624788/)", "—", "—", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:37746199(https://pubmed.ncbi.nlm.nih.gov/37746199/)", "—", "Saccharomyces cerevisiae and Komagataella phaffii (Pichia pastoris)", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**B**"], ["PMID:39100921(https://pubmed.ncbi.nlm.nih.gov/39100921/)", "—", "—", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**A**"], ["PMID:39044288(https://pubmed.ncbi.nlm.nih.gov/39044288/)", "—", "Pichia pastoris SMD1168", "pGAP", "—", "—", "—", "—", "—", "—", "—", "—", "**A**"], ["PMID:39095661(https://pubmed.ncbi.nlm.nih.gov/39095661/)", "αMF signal sequence", "PichiaPink™ strain 1 (ade2)", "pAOX1", "single-copy", "shake flask", "96 h", "—", "Spectrofluorimetry", "—", "gene dosage", "—", "**A**"], ["PMID:41502849(https://pubmed.ncbi.nlm.nih.gov/41502849/)", "SKL (Ser-Lys-Leu) motif", "Komagataella phaffii GS115", "P AOX1", "—", "shake flask", "120 h", "30.9 U/(mL·OD 600 )", "xylanase activity assay", "—", "metabolic burden of multiple heterologous gene overexpression", "—", "**B**"], ["PMID:39367390(https://pubmed.ncbi.nlm.nih.gov/39367390/)", "11 different signal peptides tested; none resulted in secretion", "Komagataella phaffii", "GAP or methanol-inducible AOX1 promoter", "—", "fed-batch bioreactor cultivations", "—", "7537 ± 66 µkat oNPGal/L culture", "volumetric β-galactosidase activity assay with oNPGal", "—", "—", "—", "**A**"], ["PMID:42930064(https://pubmed.ncbi.nlm.nih.gov/42930064/)", "EXG1-derived secretion signal", "Komagataella phaffii GS115", "constitutive (pGAPZα-A)", "three expression cassettes", "—", "—", "312.07 ± 18.37 U/mL", "—", "—", "—", "—", "**A**"], ["PMID:42830927(https://pubmed.ncbi.nlm.nih.gov/42830927/)", "S. cerevisiae α-factor signal peptide", "Komagataella phaffii (formerly Pichia pastoris)", "P AOX1", "—", "—", "—", "—", "—", "—", "—", "—", "**A**"], ["PMID:42461011(https://pubmed.ncbi.nlm.nih.gov/42461011/)", "α-mating factor (MF) signal sequence", "K. phaffii X-33", "P AOX1", "single-copy", "fed-batch cultivation", "—", "639 mg/L", "—", "—", "—", "—", "**B**"], ["PMID:41991737(https://pubmed.ncbi.nlm.nih.gov/41991737/)", "α-factor secretion signal", "Komagataella phaffii GS115", "—", "—", "—", "96 h", "~7 mg/mL", "—", "—", "—", "—", "**B**"], ["PMID:42663653(https://pubmed.ncbi.nlm.nih.gov/42663653/)", "—", "K. phaffii", "P DF promoter", "—", "bioreactor", "—", "4.36 U*mL − 1", "peroxidase activity", "—", "—", "—", "**NR**"], ["PMID:42277856(https://pubmed.ncbi.nlm.nih.gov/42277856/)", "S. cerevisiae α-factor secretion signal", "Komagataella phaffii GlycoSwitch SuperMan5", "methanol-inducible alcohol oxidase (AOX) promoter from K. phaffii", "—", "—", "—", "50 mg/L", "—", "—", "—", "—", "**NR**"], ["PMID:41084001(https://pubmed.ncbi.nlm.nih.gov/41084001/)", "Ksh1 secretion signal sequence (SP_Ksh1)", "Saccharomyces cerevisiae CEN.PK113-7D and CEN.PK113-5D", "P_TEF1 and P_HSP12", "multicopy (2µ) plasmid", "—", "—", "—", "—", "—", "—", "—", "**NR**"], ["PMID:41957036(https://pubmed.ncbi.nlm.nih.gov/41957036/)", "tissue plasminogen activator signal sequence (tPAss)", "—", "—", "—", "—", "—", "—", "—", "—", "—", "—", "**NR**"], ["PMID:41704442(https://pubmed.ncbi.nlm.nih.gov/41704442/)", "—", "HEK293 (NBX1P01 clonal derivative)", "CMV", "—", "24-well plates (small-scale), TubeSpin Bioreactor 50 (medium-scale), 3L-Erlenmeyer flasks (1.5 L)", "72 hrs", "around 10^10 vg/mL", "dPCR", "—", "Vector production titers decrease as the size of the cargo increased; AAV serotype 2 is cell membrane associated and crude vector titers are expected to be lower", "—", "**NR**"], ["PMID:40563197(https://pubmed.ncbi.nlm.nih.gov/40563197/)", "SptP 167", "Salmonella typhimurium ASTE13", "PsicA", "—", "5 mL in a 24 well block or 0.5 mL in a 96 well block", "8 h", "—", "fluorescence", "—", "—", "—", "**NR**"], ["PMID:40407690(https://pubmed.ncbi.nlm.nih.gov/40407690/)", "—", "CHO master cell line", "ChiP, chimeric promoter comprising mCMV (cytomegalovirus) enhancer, human CMV core promoter and intron", "single-copy", "5-day batch cultures", "5-day", "—", "specific productivity (qMab)", "peptide mapping", "a fraction of secreted antibodies retained 2A residues attached to the HC polypeptides", "—", "**NR**"], ["PMID:40563197(https://pubmed.ncbi.nlm.nih.gov/40563197/)", "SptP 167", "Salmonella typhimurium ASTE13", "PsicA", "—", "5 mL in a 24 well block or 0.5 mL in a 96 well block", "8 h", "—", "fluorescence", "—", "—", "—", "**NR**"]], "caption": "EVIDENCE (63 sources)"}

Fields extracted per-source from EuropePMC full text where available (with verbatim quote anchors), falling back to passage-level extraction; NR = not reported. Citations from Semantic Scholar (preprints are naturally low/zero-cited — not a quality verdict by itself). Grade: A=high / B=medium / NR=low extraction confidence — not an independent re-analysis.

Key quantitative observations:

  1. Highest reported titer: 7537 µkat oNPGal/L culture (PMID:39367390); next: 1039.06 mg/L (PMID:41886223). Different units/cultivation scales — not directly comparable.
  2. Reported titers span 1.02–7537 µkat oNPGal/L culture across 22 sources — system, host and process differences dominate; rank by leader only after matched comparisons.

References

其他引用 [1] PMID:41745279 — Genome-Wide Landscape of Position Effect Variegation in Pichia pastoris . [2] PMID:42707141 — 瘦素 / leptin expression in Komagataella phaffii [3] PMID:23756761 — 卵转铁蛋白 / ovotransferrin expression in Komagataella phaffii [4] PMID:42113077 — 干扰素α / interferon alpha expression in Komagataella phaffii [5] PMID:38711081 — Understanding exopolysaccharide byproduct formation in Komagataella phaffii fermentation processes for recombinant protein production. [6] PMID:41660601 — Overcoming the problem of heterologous proteins folding to improve the efficiency of yeast bioproducers. [7] PMID:40491503 — Improvement of D-lactic acid production from methanol by metabolically engineered Komagataella phaffii via ultra-violet mutagenesis. [8] PMID:23160737 — Endogenous signal peptides efficiently mediate the secretion of recombinant proteins in Pichia pastoris. [9] PMID:26169367 — Restriction site free cloning (RSFC) plasmid family for seamless, sequence independent cloning in Pichia pastoris. [10] PMID:41591157 — Efficient Expression of Lactone Hydrolase Cr2zen for Scalable Zearalenone Degradation in Pichia pastoris . [11] PMID:38402195 — Unlocking Nature's Toolbox: glutamate-inducible recombinant protein production from the Komagatella phaffii PEPCK promoter. [12] PMID:38483353 — A Yeast Modular Cloning (MoClo) Toolkit Expansion for Optimization of Heterologous Protein Secretion and Surface Display in Saccharomyces cerevisiae . [13] PMID:42787492 — 蛋白酶 / protease expression in Komagataella phaffii [14] catalog — protease [15] PMID:35083407 — Creation of a recombinant Komagataella phaffii strain, a producer of proteinase K from Tritirachium album. [16] PMID:36979376 — Industrial Production of Proteins with Pichia pastoris - Komagataella phaffii . [17] PMID:38730212 — Recent progress on heterologous protein production in methylotrophic yeast systems. [18] PMID:33494776 — Synergistic optimisation of expression, folding, and secretion improves E. coli AppA phytase production in Pichia pastoris. [19] PMID:38104077 — A supernumerary synthetic chromosome in Komagataella phaffii as a repository for extraneous genetic material. [20] PMID:39614978 — Engineering Komagataella phaffii for ethylene glycol production from xylose. [21] PMID:39363343 — Avoiding overflow metabolite formation in Komagataella phaffii fermentations to enhance recombinant protein production. [22] PMID:37989852 — Use of an on/off tetracycline riboswitch to control protein production in Komagataella phaffii. [23] PMID:41168757 — Next-generation stress-inducible Komagataella phaffii promoter variants. [24] PMID:37764140 — Alternative PCR-Based Approaches for Generation of Komagataella phaffii Strains. [25] PMID:40504260 — 抑肽酶 / aprotinin expression in Komagataella phaffii [26] PMID:38378464 — 干扰素β / interferon beta expression in Komagataella phaffii [27] PMID:42380967 — 鲎素 / tachyplesin expression in Komagataella phaffii [28] PMID:39582006 — Increased cytoplasmic expression of PETase enzymes in E. coli. [29] PMID:42712250 — 莫奈林 / monellin expression in Komagataella phaffii [30] PMID:41350511 — 幽门螺杆菌抗原 / Helicobacter antigen expression in Komagataella phaffii [31] PMID:41440027 — 碱性磷酸酶 / alkaline phosphatase expression in Komagataella phaffii [32] PMID:38368340 — Impact of cell wall polysaccharide modifications on the performance of Pichia pastoris: novel mutants with enhanced fitness and functionality for bioproduction applications. [33] PMID:40421287 — Promoter engineering for enhanced 3-hydroxypropionic acid production in Pichia pastoris . [34] PMID:41859725 — Yeast species resource exploration and application in cell factories. [35] PMID:39628915 — Genetic tools for metabolic engineering of Pichia pastoris . [36] PMID:38140232 — Challenges and Opportunities in the Process Development of Chimeric Vaccines. [37] PMID:40471355 — The MFα signal sequence in yeast-based protein secretion: challenges and innovations'. [38] PMID:40900179 — Efficient secretory expression of type III recombinant human collagen with triple-helical structure in Komagataella phaffii. [39] PMID:42819341 — 降钙素 / calcitonin expression in Komagataella phaffii [40] PMID:40319267 — A toolkit for facilitating markerless integration of expression cassettes in Komagataella phaffii via CRISPR/Cas9. [41] PMID:35435127 — 神秘果蛋白 / miraculin expression in Komagataella phaffii [42] PMID:41886223 — 类胶原蛋白 / collagen-like protein expression in Komagataella phaffii [43] PMID:34284814 — 内皮抑素 / endostatin expression in Komagataella phaffii [44] PMID:8954896 — Production and purification of recombinant hirudin expressed in the methylotrophic yeast Pichia pastoris. [45] PMID:26285758 — Recombinant Expression of Trichoderma reesei Cel61A in Pichia pastoris: Optimizing Yield and N-terminal Processing. [46] PMID:14586125 — Efficient production of recombinant human pleiotrophin in yeast, Pichia pastoris. [47] PMID:35127675 — Strategies for Heterologous Expression, Synthesis, and Purification of Animal Venom Toxins. [48] PMID:39624788 — Tyrosinases: a family of copper-containing metalloenzymes. [49] PMID:37746199 — Burden Imposed by Heterologous Protein Production in Two Major Industrial Yeast Cell Factories: Identifying Sources and Mitigation Strategies. [50] PMID:39100921 — What are the 100 most cited fungal genera? [51] PMC:PMC7302841 — G-protein-coupled Receptors in Fungi [52] PMC:PMC12307969 — Posters [53] PMID:39044288 — Novel transcriptional regulation of the GAP promoter in Pichia pastoris towards high expression of heterologous proteins. [54] PMID:39095661 — Hansenula polymorpha methanol metabolism genes enhance recombinant protein production in Komagataella phaffi. [55] PMID:41502849 — Formatotrophic Komagataella phaffii expressing recombinant xylanase via metabolic engineering. [56] PMID:39367390 — Recombinant production of Paenibacillus wynnii β-galactosidase with Komagataella phaffii. [57] PMID:42930064 — High-Level Constitutive Secretory Expression and Low-Temperature Adaptation Engineering of the Acid Protease RMAP9 from the Mangrove-Derived Yeast Rhodotorula mucilaginosa. [58] PMID:42830927 — Systematic optimization of Komagataella phaffii (Pichia pastoris) for high-efficiency recombinant protein production: Advancements in strain engineering, fermentation optimization, and AI-driven technologies. [59] PMID:42461011 — Metabolic engineering of Komagataella phaffii for enhanced production of heterologous proteins and small molecules: key strategies and future directions. [60] PMID:41991737 — Optimized expression and antimicrobial activity of rainbow trout defensin 3 in Komagataella phaffii. [61] PMID:42663653 — Thinking big in small scale: characterization of peroxidase production in Komagataella phaffii using two-compartment scale-down system. [62] PMID:42277856 — Engineering Komagataella phaffii for secreted and surface-displayed production of SARS-CoV-2 receptor-binding domain and its immunogenicity evaluation. [63] PATENT:MX2009012609 — COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS. [64] PATENT:CN101144093 — Recombination expression carrier and method for soluble expressing human I-type metallothionin [65] PATENT:WO2008153745 — COMPOSITIONS AND METHODS FOR PRODUCING BIOACTIVE FUSION PROTEINS [66] PMID:37513276 — Turgencin抗菌肽 / turgencin expression in Komagataella phaffii [67] PMID:42915636 — 索马甜 / thaumatin expression in Komagataella phaffii [68] PMID:36620045 — Comparative transcriptomic analysis-based identification of the regulation of foreign proteins with different stabilities expressed in Pichia pastoris . [69] PMID:24133976 — 激肽释放酶结合蛋白 / kallistatin expression in Komagataella phaffii [70] PMID:38133203 — Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes. [71] PMID:42031168 — Identification of novel ubiquitin receptors on the 26S proteasome by photo-crosslinking mass spectrometry. [72] PMID:41062940 — A LjBAK1-associated E3 ubiquitin ligase, LjPUB7, negatively regulates early symbiosis by targeting NFRs. [73] PMID:32107274 — Protein Engineering in the Ubiquitin System: Tools for Discovery and Beyond. [74] PMID:41423278 — Global Transcriptomic Analysis Identifies Gene Expression Programs Regulated by α-Factor in Yeast. [75] PMID:42025218 — Yeast MoClo Secretion and Surface Display Toolkit 2.0: Improvements and Applications for Analysis of protein-protein Interactions and Whole-Cell Biocatalysis. [76] PMID:41084001 — Uncoupling protein production from growth: different strategies for intracellular and secreted proteins in yeast. [77] PMID:41957036 — Fc-free single-chain antibody mRNA therapy for airway infection of multidrug-resistant Pseudomonas aeruginosa. [78] PMID:41704442 — Generation and characterization of a HEK293 cell line optimized for recombinant adeno-associated virus production. [79] PMID:40563197 — A high throughput assay for measuring secreted protein based on a de novo fluorescent reporter reveals regulatory and structural insights in Salmonella type three secretion system. [80] PMID:40407690 — A Targeted Integration-Based CHO Cell Platform for Simultaneous Antibody Display and Secretion. [81] PMID:40563197 — A high throughput assay for measuring secreted protein based on a de novo fluorescent reporter reveals regulatory and structural insights in Salmonella type three secretion system. [82] PMID:29648592 — Yeast 2.0-connecting the dots in the construction of the world's first functional synthetic eukaryotic genome. [83] PMID:41685350 — An ELIXIR scoping review on domain-specific evaluation metrics for synthetic data in life sciences. [84] PMID:36076913 — Rational Design of Lipase ROL to Increase Its Thermostability for Production of Structured Tags. [85] PMID:41278200 — ER-resident proteins are key players in cartilage and bone homeostasis.

Kairos v0.54.8. Evidence-grounded research guidance + verifiable dry-lab design artifacts. Proposes hypotheses and pre-experiment designs — NOT an expression/titer prediction or a guarantee. Validate at the bench; measured-outcome return remains planned roadmap work.

Turn this example into an auditable dossier for your own target. Open Kairos →